EFFICACY OF BENZONIDAZOLE IN THE SURVIVAL OF IMMUNOSUPPRESSED PATIENTS DUE TO REACTIVATION OF CHAGAS DISEASE. Editora Impacto Científico, [S. l.], p. 160–173, 2025. DOI: 10.56238/edimpacto2025.064-011. Disponível em: https://periodicosnewscience.com.br/editoraimpacto/article/view/7517. Acesso em: 3 mar. 2026.